RETRACTED: Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2
- DOI
- 10.1021/acsomega.3c01296
- Published
- 2023-05-23
- Container
- ACS Omega
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acsomega.3c01296,
title = {RETRACTED: Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2},
author = {Ming-feng Yang and Sheng-yao Sun and Hai-guang Lv and Wei-qi Wang and Han-xia Li and Jing-yi Sun and Zong-yong Zhang},
year = {2023},
journal = {ACS Omega},
doi = {10.1021/acsomega.3c01296},
url = {https://doi.org/10.1021/acsomega.3c01296}
}RIS
TY - JOUR TI - RETRACTED: Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2 AU - Ming-feng Yang AU - Sheng-yao Sun AU - Hai-guang Lv AU - Wei-qi Wang AU - Han-xia Li AU - Jing-yi Sun AU - Zong-yong Zhang PY - 2023 JO - ACS Omega DO - 10.1021/acsomega.3c01296 UR - https://doi.org/10.1021/acsomega.3c01296 ER -
APA
Yang, M., Sun, S., Lv, H., Wang, W., Li, H., Sun, J., & Zhang, Z. (2023). RETRACTED: Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2. ACS Omega. https://doi.org/10.1021/acsomega.3c01296
Source records
- crossref · retrieved 2026-11-10T11:38:27.643Z